READs2023: China's First Nanopore Sequencing Summit Unveils Three Key Highlights and New Product Launch in Chengdu

As a core upstream segment of the genetic industry chain, gene sequencing technology plays a pivotal role in driving the rapid development of the entire sector. Currently, with the emergence of a trillion-level precision medicine market, gene sequencing is evolving toward longer read lengths, faster speeds, and greater portability. Nanopore sequencing has become a technological focus for an increasing number of experts, scholars, and industry users. How to leverage its advantages—such as long read lengths, real-time sequencing, and compact portability—and how to explore the myriad possibilities of this technology at the application level have become hot topics of discussion within the industry.

On August 18, the “READs2023·China Nanopore Gene Sequencing Summit” will be held in Chengdu, Sichuan Province. Centered on the theme “Peering Through Pores, Envisioning the Future,” the summit will bring together numerous experts, scholars, and seasoned users from the sequencing industry. Through academic exchanges and intellectual discourse, participants will discuss the historical evolution and future prospects of gene sequencing technologies, explore the opportunities and challenges for the domestication of nanopore gene sequencing technology in China, and strategize on new market applications for nanopore sequencing in the new era.

It is reported that this summit is the first industry event in China to focus on the development and application of nanopore sequencing technology, featuring three major highlights:

First, a gathering of industry leaders is set to inject new momentum into the sector. It is reported that the conference has specially invited academicians and senior experts from prestigious institutions across various fields—including the Chinese Center for Disease Control and Prevention, Peking University People’s Hospital, Peking University Third Hospital, Sichuan University, West China Hospital, the National Center for Biomedical Analysis, and the Institute of Microbiology of the Chinese Academy of Sciences—to convene in Chengdu. Standing at the cusp of generational transformation in gene sequencing, these experts will employ a forward-looking perspective to examine how next-generation sequencing technologies can unlock their potential and benefit public welfare.

Secondly, the conference features a rich agenda that showcases the current applications and potential of nanopore sequencing technology from multiple dimensions. Distinguished experts and scholars from various fields will be invited to deliver academic presentations on clinical and research application scenarios, including pathogen research, public health epidemic prevention, animal disease control, precision tumor diagnosis, clinical infections, and forensic identification. They will discuss the advantageous applications of nanopore sequencing technology and its future development directions.

Finally, the conference aims to build a broad platform for exchange and cooperation, promote the interconnectivity of industry, academia, research, and application, jointly drive the high-quality development of frontier technologies from research to application, fully leverage the driving role of gene sequencers as the “root” technology of the industry across the entire industrial chain, and thereby accelerate the independent and rapid development of China’s gene sequencing industry.

Stay tuned for more exciting highlights!